PDS Biotechnology Corporation - stock earnings
PDSB Quarterly earnings
| Date | Earnings | Revenue |
|---|---|---|
| 2023Q3 | -10.8 million USD | ? USD |
| 2023Q2 | -11.5 million USD | ? USD |
| 2023Q1 | -9.7 million USD | ? USD |
| 2022Q4 | -21.5 million USD | ? USD |
| 2022Q3 | -7.4 million USD | ? USD |
| 2022Q2 | -5.8 million USD | ? USD |
| 2022Q1 | -8.5 million USD | ? USD |
| 2021Q4 | -6.3 million USD | ? USD |
| 2021Q3 | -7.0 million USD | ? USD |
| 2021Q2 | -588931 USD | ? USD |
| 2021Q1 | -3.0 million USD | ? USD |
| 2020Q4 | -4.0 million USD | ? USD |
| 2020Q3 | -3.9 million USD | ? USD |
| 2020Q2 | -2.9 million USD | ? USD |
| 2020Q1 | -4.0 million USD | ? USD |
| 2019Q4 | -4.2 million USD | ? USD |
| 2019Q3 | -5.8 million USD | ? USD |
| 2019Q2 | -3.9 million USD | ? USD |
| 2019Q1 | 6.8 million USD | ? USD |
| 2018Q4 | -3.1 million USD | ? USD |
| 2018Q3 | -4.3 million USD | ? USD |
| 2018Q2 | -12.7 million USD | ? USD |
| 2018Q1 | -20.8 million USD | ? USD |
| 2017Q4 | -13.9 million USD | ? USD |
| 2017Q3 | -11.3 million USD | ? USD |
| 2017Q2 | -13.5 million USD | ? USD |
| 2017Q1 | -12.2 million USD | ? USD |
| 2016Q4 | -9.5 million USD | ? USD |
| 2016Q3 | -10.8 million USD | ? USD |
| 2016Q2 | -9.4 million USD | ? USD |
| 2016Q1 | -9.2 million USD | ? USD |
| 2015Q4 | -8.0 million USD | ? USD |
| 2015Q3 | -10.1 million USD | ? USD |
| 2015Q2 | -5.5 million USD | ? USD |
| 2015Q1 | -4.5 million USD | ? USD |
| 2014Q4 | -3.2 million USD | ? USD |
| 2014Q3 | -3.5 million USD | ? USD |
PDSB Yearly earnings
| Date | Earnings | Revenue |
|---|---|---|
| 2023 | -51.2 million USD | ? USD |
| 2022 | -40.9 million USD | ? USD |
| 2021 | -16.9 million USD | ? USD |
| 2020 | -14.8 million USD | ? USD |
| 2019 | -7.0 million USD | ? USD |
| 2018 | -40.9 million USD | ? USD |
| 2017 | -50.9 million USD | ? USD |
| 2016 | -38.8 million USD | ? USD |
| 2015 | -28.1 million USD | ? USD |
| 2014 | -12.2 million USD | ? USD |
| 2013 | -6.9 million USD | ? USD |
PDSB
Price: $3.82
52 week price:
Earnings Per Share: -1.39 USD
P/E Ratio: -3.20
Exchange: NCM
Sector: Healthcare
Industry: Biotechnology
Volume: 392200
Market Capitalization: 140.1 million